Abstract
SummaryAkathisia remains one of the most prevalent and distressful
antipsychotic-induced adverse events. Effective and well-tolerated treatment
is a major unmet need in akathisia that merits a search for new remedies.
Accumulating evidence indicates that agents with marked serotonin-2A
receptor antagonism may represent a new class of potential anti-akathisia
treatment.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献